Neuropathy, hereditary sensory and autonomic, type 2A: genes and variants
Explore variant evidence for Neuropathy, hereditary sensory and autonomic, type 2A across 2 analyzed proteins (SCN9A, KIF1A). Linked ClinVar records include 15 pathogenic or likely pathogenic variants, 1,142 variants of uncertain significance and 72 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Neuropathy, hereditary sensory and autonomic, type 2A
SCN9A: Sodium channel protein type 9 subunit alpha
The protein forms Nav1.7, a voltage-gated sodium channel that amplifies electrical signals in peripheral sensory neurons. Changes in Nav1.7 activity can produce either excessive pain or congenital insensitivity to pain, making SCN9A central to pain biology.
14 ClinVar pathogenic / likely pathogenic and 1,213 uncertain variants in SCN9A have source records linked to Neuropathy, hereditary sensory and autonomic, type 2A. Association strength is not clinical gene validity.
KIF1A: Kinesin-like protein KIF1A
It transports synaptic vesicle precursors and other cargo along axonal microtubules toward nerve terminals. Pathogenic variants cause a broad KIF1A-associated neurological disorder spectrum including hereditary sensory neuropathy, spastic paraplegia, optic atrophy, ataxia, and developmental impairment.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in KIF1A have source records linked to Neuropathy, hereditary sensory and autonomic, type 2A. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Neuropathy, hereditary sensory and autonomic, type 2A
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SCN9A V1310F | 1310 | III | Pathogenic / likely pathogenic (★★) |
| SCN9A R907W | 907 | II | Pathogenic / likely pathogenic (★★) |
| SCN9A I1472T | 1472 | III | Pathogenic / likely pathogenic (★★) |
| SCN9A R907Q | 907 | II | Pathogenic / likely pathogenic (★★) |
| SCN9A V400M | 400 | I | Pathogenic / likely pathogenic (★★) |
| SCN9A I859T | 859 | II | Pathogenic / likely pathogenic (★★) |
| SCN9A L869H | 869 | II | Pathogenic / likely pathogenic (★★) |
| SCN9A I1472N | 1472 | III | Pathogenic / likely pathogenic (★) |
| SCN9A V1310I | 1310 | III | Pathogenic / likely pathogenic (★) |
| SCN9A T1475I | 1475 | III | Pathogenic / likely pathogenic (★) |
| SCN9A I234T | 234 | I | Pathogenic / likely pathogenic (★) |
| SCN9A G867R | 867 | II | Pathogenic / likely pathogenic (★) |
| KIF1A N211D | 211 | Kinesin motor | Pathogenic / likely pathogenic (★) |
| SCN9A A1143P | 1143 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SCN9A D1959A | 1959 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Neuropathy, hereditary sensory and autonomic, type 2A
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 89 out of 100
- ESM1b (LLR): 86 out of 100
- PolyPhen-2: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 83 out of 100
- MutPred: 75 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Primary erythermalgia also has ClinVar records linked to SCN9A variants; they fall mostly in different places as the Neuropathy, hereditary sensory and autonomic, type 2A variants (6 pathogenic / likely pathogenic).
- Paroxysmal extreme pain disorder also has ClinVar records linked to SCN9A variants; they fall partly in the same places as the Neuropathy, hereditary sensory and autonomic, type 2A variants (4 pathogenic / likely pathogenic).
- Hereditary spastic paraplegia also has ClinVar records linked to KIF1A variants; they fall mostly in different places as the Neuropathy, hereditary sensory and autonomic, type 2A variants (44 pathogenic / likely pathogenic).
- Neuropathy, hereditary sensory also has ClinVar records linked to KIF1A variants; they fall mostly in different places as the Neuropathy, hereditary sensory and autonomic, type 2A variants (26 pathogenic / likely pathogenic).
Diseases related to Neuropathy, hereditary sensory and autonomic, type 2A
- Hereditary spastic paraplegia, also linked to KIF1A
- Amyotrophic lateral sclerosis, also linked to SCN9A
- Generalized epilepsy with febrile seizures plus, also linked to SCN9A
- Cardiac arrhythmia, also linked to SCN9A
- Neuropathy, hereditary sensory, also linked to KIF1A
- Epilepsy, also linked to SCN9A
- Primary erythermalgia, also linked to SCN9A
- Paroxysmal extreme pain disorder, also linked to SCN9A
- Focal epilepsy, also linked to SCN9A
- Channelopathy-associated congenital insensitivity to pain, also linked to SCN9A
- Migraine, also linked to SCN9A
- Lennox-Gastaut syndrome, also linked to SCN9A
Frequently asked questions
Which genes have records linked to Neuropathy, hereditary sensory and autonomic, type 2A?
This view contains 2 analyzed proteins: SCN9A, KIF1A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 15 pathogenic or likely pathogenic variants, 1,142 variants of uncertain significance and 72 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,260 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center